Clinical trial
Pramipexole in Bipolar Disorder: Targeting Cognition (PRAM-BD)
NCT02397837 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pramipexole in Bipolar Disorder: Targeting Cognition (PRAM-BD)
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- July 26, 2018
- Enrollment
- 103 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.